358 related articles for article (PubMed ID: 2418463)
1. Diagnosis and management of multiple myeloma and related disorders.
Kyle RA
Prog Hematol; 1986; 14():257-82. PubMed ID: 2418463
[No Abstract] [Full Text] [Related]
2. Advances in the diagnosis and management of myeloma.
Greipp PR
Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293
[No Abstract] [Full Text] [Related]
3. [Multiple myeloma and other plasma cell dyscrasias].
del Potro Gómez E; Morales Sanz D
Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
[No Abstract] [Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
5. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B; Castillo JJ; Sarosiek S; Beksac M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and therapy of multiple myeloma: current aspects].
Betticher DC; Cerny T; Fey MF
Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
[TBL] [Abstract][Full Text] [Related]
7. Paraproteinemias and the lungs.
Sharma OP
Curr Opin Pulm Med; 2005 Sep; 11(5):408-11. PubMed ID: 16093814
[No Abstract] [Full Text] [Related]
8. Myeloma and macroglobulinemia: what are the criteria for diagnosis?
Stone MJ
Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951
[TBL] [Abstract][Full Text] [Related]
9. Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience.
Hernández-Reyes J; Galo-Hooker E; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2012; 64(6 Pt 2):604-8. PubMed ID: 23593777
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
Rajkumar SV; Dispenzieri A; Kyle RA
Mayo Clin Proc; 2006 May; 81(5):693-703. PubMed ID: 16706268
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell neoplasms.
Alexanian R
CA Cancer J Clin; 1976; 26(1):38-49. PubMed ID: 812592
[No Abstract] [Full Text] [Related]
12. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal gammopathy and osteolytic lesions as the initial manifestation of a metastatic hypernephroma].
Castillo Jimeno JM; Illarramendi Mañas JJ; Ruiz Rubio JL; Santiago González A; Sebastián Borruel JL
Arch Esp Urol; 1991 Nov; 44(9):1110-2. PubMed ID: 1807217
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic significance of finding a M-component in serum].
Schmidt EB; Møller-Petersen J
Ugeskr Laeger; 1986 Mar; 148(11):633-5. PubMed ID: 3083549
[No Abstract] [Full Text] [Related]
15. Multiple complications in multiple myeloma.
Basi S; Schulman G; Fogo AB
Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
[No Abstract] [Full Text] [Related]
16. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
Graziani MS; Merlini G
Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
[TBL] [Abstract][Full Text] [Related]
17. [Paraproteinemic hemoblastosis].
Rybakova ME
Med Sestra; 1977 Aug; 36(8):37-40. PubMed ID: 414047
[No Abstract] [Full Text] [Related]
18. [Multiple myeloma. Biological, prognostic, and therapeutic aspects].
Corrado C; Pavlovsky S
Sangre (Barc); 1990 Aug; 35(4):289-97. PubMed ID: 1703328
[No Abstract] [Full Text] [Related]
19. Clinical practice. Monoclonal gammopathy of undetermined significance.
Bladé J
N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
[No Abstract] [Full Text] [Related]
20. [Monoclonal gammopathy--multiple myeloma].
Dietzfelbinger H
MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]